Thu, Dec 18, 2014, 9:14 AM EST - U.S. Markets open in 16 mins.

Recent

% | $
Quotes you view appear here for quick access.

Sangamo Biosciences Inc. Message Board

  • nybtman nybtman Mar 15, 2013 9:12 AM Flag

    Sangamo will provide framework for Functional Cure of HIV at ASGCT in May

    At the American Society of Gene and Cell Therapy (May 15-18, 2013), Sangamo will be providing oral presentation on preliminary results of their Phase 2 for their SB-728-T therapeutic. Sangamo has already announced since last week Phase 2 results will be presented. However, decisions on acceptance by ASGCT was to be made by mid-March, which is today (per their website). You know it must be exceptional to get an Early Decision. If it is continuation and expansion of the unprecedented results they have presented so far for their Phase 1 results (focusing on safety and efficacy), I think you will see the exceptional Phase 2 results which provides framework for a HIV Functional Cure.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
SGMO
14.91+1.69(+11.33%)Dec 17 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Rite Aid Corporation
NYSEWed, Dec 17, 2014 4:01 PM EST
Accenture plc
NYSEWed, Dec 17, 2014 4:00 PM EST
Volcano Corporation
NasdaqGSWed, Dec 17, 2014 4:00 PM EST